Intended for healthcare professionals

CCBYNC Open access
Research

Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4823 (Published 22 September 2016) Cite this as: BMJ 2016;354:i4823